Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Insulet Corporation, a Massachusetts-based medical device company focused on diabetes technology, announced that its Omnipod 5 Automated Insulin Delivery System is now cleared by the U.S. Food and Drug Administration (FDA) to manage type 2 diabetes (T2D).

FDA clears first automated insulin pump for type 2 diabetes

Insulet's Omnipod 5 Automated Insulin Delivery System was already cleared to help patients manage type 1 diabetes. 

sonographer echo

Cardiology groups share new AUC for cardiovascular imaging prior to noncardiac surgery

The new AUC document was designed to help care teams know when and how to perform imaging-based cardiovascular evaluations on patients undergoing nonemergent, noncardiac surgery.

Boston Scientific TAVR ACURATE Prime Aortic Valve System

Boston Scientific’s new TAVR valve gains CE mark approval

The self-expanding Acurate Prime Aortic Valve System was designed with improved valve positioning in mind. According to Boston Scientific, it it will be available in more sizes than the company's previous TAVR device to ensure it can treat as many heart patients as possible. 

Thumbnail

Political intervention necessary to preserve ‘vanishing’ small independent practices, experts charge

Such organizations often lack the required IT infrastructure, population health expertise and relationships to navigate value-based care models. 

Thumbnail

Outpatient radiology providers missing the mark when communicating costs to patients

About 17% of healthcare consumers were aware of one health system's estimator tool, but 0% had used it, according to new survey data. 

Medicare coverage for weight loss drug semaglutide could cost up to $145B per year

Medications that target obesity are not typically covered by Medicare. When the FDA approved semaglutide as a way to treat certain cardiovascular risks, however, CMS said Medicare coverage was on the table. 

Thumbnail

Radiologists, anesthesiologists and emergency medicine physicians implore feds to finalize rule

“This instability is putting in jeopardy our collective ability to meet the core objective of the No Surprises Act: to protect patients," ACR and others wrote recently. 

Immigration attorney Kathleen Campbell Walker explains how can immigration help solve the healthcare staffing shortages.

Immigration barriers prevent solution to healthcare staffing shortages

Kathleen Campbell Walker, JD, immigration practice attorney, and past president of the American Immigration Lawyers Association (AILA), explains the barriers to global physician mobility amid growing shortages.